PATENT CLAIM ANALYSIS

Application Number: 15759872
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-07
Patent Classification: ["514", "229200"]

Abstract:
The present invention provides a compound having the basic structure shown by Formula (I) in which the indole ring and the pyrazolopyridine structure is bound through a substituent, a salt thereof or a solvate of either the compound or a salt of the compound, as well as a preventative agent or a therapeutic agent for non-insulin-dependent diabetes mellitus (Type 2 diabetes) or obesity containing such compound, salt or solvate as an active ingredient.

Claim (Index 4):
The compound according to  claim 1 , a salt thereof, or a solvate of either the compound or a salt of the compound, wherein Z 2  is selected from C 1-6  alkyl, C 3-15  cycloalkyl, 3 to 12 membered heterocyclyl, C 6-10  aryl, and 5 to 10 membered heteroaryl, wherein C 3-15  cycloalkyl, 3 to 12 membered heterocyclyl, C 6-10  aryl, and 5 to 10 membered heteroaryl are optionally substituted with one to four substituents independently selected from Group B: Group B: a) oxo,\n b) a halogen atom, \n c) \u2014NR zdl R zel ; wherein R zdl  and R zel  are independently selected from a hydrogen atom, C 1-6  alkyl and (C 1-6  alkyl)carbonyl, and C 1-6  alkyl is optionally substituted with one or more C 1-6  alkoxy, \n d) \u2014S(\u2550O) n7 \u2014R zhl ; wherein n7 is an integer of 0 to 2, R z hl is C 1-6  alkyl, \n e) C 1-6  alkyl; wherein C 1-6  alkyl is optionally substituted with one or more substituents independently selected from a halogen atom, hydroxy, \u2014NR zi R rj , C 1-6  alkoxy, and 3 to 12 membered heterocyclyl, wherein R zi  and R zj  are independently a hydrogen atom or C 1-6  alkyl, and wherein 3 to 12 membered heterocyclyl is optionally substituted with one or more substituents independently selected from hydroxy, C 1-6  alkyl and 3 to 12 membered heterocyclyl, \n f) C 1-6  alkoxy; wherein C 1-6  alkoxy is optionally substituted with one or more hydroxy, \n g) 3 to 12 membered heterocyclyl; wherein 3 to 12 membered heterocyclyl is optionally substituted with one or more (C 1-6  alkyl)carbonyl, \n h) 5 to 10 membered heteroaryl; wherein 5 to 10 membered heteroaryl is optionally substituted with one or more substituents independently selected from C 1-6  alkyl, and \u2014NR zkl R zll ; and R zkl  and R zll  are independently selected from a hydrogen atom and C 1-6  alkyl.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 90.0
- Lexical Diversity: 1.58824
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14852738', '13126490', '11778796', '14376307', '15523954']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7780400733615747
- 35 USC 102 Novelty (BERT): 0.5484865321050766
- Combined Prediction Score: 0.7550847192359249
- Mean Citation Score: 349.31223
- Max Citation Score: 389.41275
- Similarity Product: 305.6415760699064

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test